首页> 外文期刊>American journal of medical genetics, Part B. Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics >Mitochondrial DNA (mtDNA) in brain samples from patients with major psychiatric disorders: Gene expression profiles, MtDNA content and presence of the MtDNA common deletion
【24h】

Mitochondrial DNA (mtDNA) in brain samples from patients with major psychiatric disorders: Gene expression profiles, MtDNA content and presence of the MtDNA common deletion

机译:患有严重精神疾病的患者脑样本中的线粒体DNA(mtDNA):基因表达谱,MtDNA含量和MtDNA常见缺失的存在

获取原文
获取原文并翻译 | 示例
           

摘要

Several lines of evidence support a mitochondrial dysfunction in major psychiatric disorders. The objective of this study was to determine whether mitochondrial DNA (mtDNA) expression or content are implicated in the mitochondrial dysfunction observed in schizophrenia (SCH), bipolar disorder (BD), and major depressive disorder (MDD). MtDNA gene expression and mtDNA content (including the MT-ND4 deletion) were measured by RT-qPCR and qPCR, respectively. Post-mortem brain tissue from 60 subjects, divided evenly into four diagnostic groups (SCH, BD, MDD, and control (C)), was analyzed. MT-ND1 gene expression was significantly increased in the BD group compared with the C group. MDD and SCH patients showed a similar pattern of mtDNA expression, which was different from that in BD patients. Similarly, a larger number of MDD and SCH patients tended to have the MT-ND4 gene deleted compared with BD and C subjects. However, no other significant differences were observed in mtDNA gene expression and mtDNA content. Notably, high variability was observed in the mtDNA gene expression and content in each diagnostic group. Previous studies and the present work provide evidence for a role of mtDNA in SCH, BD and MDD. However, further studies with larger patient and control groups as well as by analyzing distinct brain regions are needed to elucidate the role of mtDNA in major psychiatric disorders. ? 2013 Wiley Periodicals, Inc.
机译:有几条证据支持主要精神疾病中的线粒体功能障碍。这项研究的目的是确定在精神分裂症(SCH),双相情感障碍(BD)和重度抑郁症(MDD)中观察到的线粒体功能障碍是否涉及线粒体DNA(mtDNA)的表达或含量。通过RT-qPCR和qPCR分别测量MtDNA基因表达和mtDNA含量(包括MT-ND4缺失)。分析了来自60位受试者的尸检后脑组织,将其平均分为四个诊断组(SCH,BD,MDD和对照(C))。与C组相比,BD组MT-ND1基因表达显着增加。 MDD和SCH患者表现出相似的mtDNA表达模式,这与BD患者不同。同样,与BD和C对象相比,更多的MDD和SCH患者倾向于删除MT-ND4基因。但是,在mtDNA基因表达和mtDNA含量方面未观察到其他显着差异。值得注意的是,每个诊断组的mtDNA基因表达和含量均存在高变异性。先前的研究和当前的工作为mtDNA在SCH,BD和MDD中的作用提供了证据。但是,需要进一步的研究,以更大的患者和对照组以及分析不同的大脑区域来阐明mtDNA在主要精神疾病中的作用。 ? 2013 Wiley期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号